关键词: font-size:medium, ">量化评价；PMC指数模型；生物医药产业政策；政策评价

Abstract: Objective： The biomedical industry is an important civilian production industry related to the life and health of the people， and policies are crucial to industrial development. This paper intends to quantitatively evaluate the existing policies to promote the high-quality development of biomedical industry in China， and provide reference for the formulation and improvement of subsequent relevant policies. Methods： The ROST CM 6.0 text mining method was used to process 12 representative biomedical industry policy documents issued by the national and provincial people′s governments and the Drug Administration from 2019 to 2023， and the PMC index evaluation model of the high-quality development policy of the biomedical industry was established， and 12 policies were quantitatively evaluated and analyzed by 10 primary variables and 40 secondary variables. Results： Among the 12 policies， 8 were excellent and 4 were good. The average PMC index is 7.17， which is generally at an excellent level， but there is still room for improvement. Through comparison， it is found that two policies with low average PMC index mainly score lower on variables such as policy objectives， policy priorities， and incentive measures. Excellent policies are P1， P2， P3， P9， P4， P8， P12， P7. Conclusion： At present， the quality of policies related to the high-quality development of China′s biomedical industry is high， and it has excellent performance in terms of financial investment， R&D support， and service guarantee of incentive measures， and can further improve the policy content from the aspects of clarifying development goals， intellectual property protection， and the whole industrial chain and supply chain.

Key words: Quantitative evaluation, PMC index model, Biomedical industry policy, Policy evaluation